InflaRx N.V. Profit Margin

InflaRx N.V. (IFRX) currently reports a profit margin of 332494.35% as of June 2026. That compares with -27815.69% in the prior-year period — up 1295.3% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore InflaRx N.V.'s profit margin history and peer comparisons.

InflaRx N.V.'s profit margin increased from -27815.69% to 332494.35% — a 1295.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

InflaRx N.V.'s profit margin of 332494.35% is higher than the Healthcare sector average of 13.89%. That is roughly 2393138.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but InflaRx N.V.'s current 332494.35% should be judged against Healthcare norms (sector average: 13.89%) and against IFRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 332494.35%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for InflaRx N.V., and consider following IFRX for alerts when major investors trade the stock.